Corrigendum to “Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies” [J hepatol 67 (2017) 999–1008]
| Image |  |
|---|---|
| Description | scholarly article published in Journal of Hepatology |
| Author/s |
author: Josep M. Llovet Jordi Bruix Keiko Nakajima Gerold Meinhardt Yoriko De Sanctis Ann-Lii Cheng |
| Publication date | October 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |